Evaluation of the effectiveness of dexmedetomidine with sufentanil in combination with intrathecal ropivacaine on analgesia in cesarean sectio

Phase 1

Recruiting

Conditions: O75.82
Cesarean section.
Onset (spontaneous) of labor after 37 completed weeks of gestation but before 39 completed weeks gestation, with delivery by (planned) cesarean section

Registration Number: IRCT20201212049688N1

Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 136

Inclusion Criteria

singleton and term pregnant women 18 to 45 years.
Having a body mass of 18 to 30.
Patients referred for elective cesarean section, who are classified as Class I according to the American Society of Anesthesiology (A.S.A).

Exclusion Criteria

Having any underlying disease
History of allergy to local anesthetic
Coagulation disorders,
local skin infection at the site of spinal anesthesia
Surgery Emergency cesarean section
Cases where we have to undergo general anesthesia during surgery

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time of onset of analgesia. Timepoint: 1,2,4,6,8,10,12,16,20,24 hours after the end of the surgery. Method of measurement: With Visual Analog Scale.;Duration of analgesia. Timepoint: 1,2,4,6,8,10,12,16,20,24 hours after the end of the surgery. Method of measurement: With Visual Analog Scale.

Secondary Outcome Measures

Name	Time	Method
Blood pressure changes. Timepoint: In minutes 1,5,10,15,20,25,30,60 after injection. Method of measurement: By barometer and registration in the relevant forms.;Nausea. Timepoint: After the intervention. Method of measurement: By asking the patient questions and observing objectively.;Vomiting. Timepoint: After the intervention. Method of measurement: By asking the patient questions and observing objectively.;Headache. Timepoint: After the intervention. Method of measurement: By Visual Analog Scale.;Heart rate. Timepoint: In minutes 1,5,10,15,20,25,30,60 after injection. Method of measurement: By pulse oximeter.;Respiratory distress. Timepoint: After the intervention. Method of measurement: By objective observation.